Date: 2016-07-29
Type of information: Loan
Company: Biophytis (France)
Investors: Bpifrance (France)
Amount: € 1.1 million
Funding type: loan
Planned used:
- The funds will be used to finance the pharmacokinetic
trial of Sarconeos (SARA-PK). This trial will assess
pharmacokinetics and safety of Sarconeos in elderly healthy volunteers (> 65 years old). The results of the trial will support the clinical and regulatory filing for Sarconeos, required for authorization of the SARA-INT clinical study (Phase 2b) initiation, currently scheduled to start in the first half of 2017 in target countries (France, Belgium, Italy and USA).
Others: • On July 29, 2016, Biophytis announced that is has received approval of bpifrance for a 1.1 million euros innovation loan to finance the pharmacokinetic trial of Sarconeos (SARA-PK).
Therapeutic area: Muscle disorders
Is general: Yes
